Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -5.38 | -23.37 |
PEG Ratio (TTM) | -0.34 | -7.10 |
P/S Ratio (TTM) | 1.53 | 44.34 |
P/B Ratio (TTM) | -279.48 | 33.03 |
P/FCF Ratio (TTM) | -0.35 | -7.73 |
Price to 5YR AVG Earnings Ratio | -1.10 | -7.08 |
Price to 5YR AVG FCF Ratio | -0.17 | -13.02 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -64.62% | -15.67% |
ROE (TTM) | -322.46% | 27.44% |
Net Profit Margin (TTM) | -565.74% | -627.99% |
ROIC 5YR AVG | -76.54% | -4.84% |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 11.97% | 4.82% | 23.20% |
Revenue | 13.23% | 114.86% | 212.57% |
Net Income | 1.61% | -3.80% | 12.34% |
Cash Flow | -88.70% | -18.33% | 4.58% |
Health (7%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.51 | 5.66 |
Quick Ratio (TTM) | 0.33 | 5.44 |
D/E Ratio (TTM) | -12.20 | 1.19 |
Interest Coverage (TTM) | -19.69 | -5.92 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | N/A | 13.21 |
LTL to 5YR AVG FCF | -0.47 | 0.09 |
Shares Outstanding Growth 5YR AVG | 16.67% | 39.51% |